Table of Contents

1 Study Coverage

• 1.1 Flu Shots Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Flu Shots Market Size Growth Rate by Product
  • 1.4.2 Influenza Virus Split Vaccines
  • 1.4.3 Influenza Virus Subunit Vaccines
  • 1.4.4 Influenza Whole Virus Vaccines
• 1.5 Market by End User
  • 1.5.1 Global Flu Shots Market Size Growth Rate by End User
  • 1.5.2 Avian Influenza virus-A
  • 1.5.3 Avian Influenza virus-B
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Flu Shots Market Size
  • 2.1.1 Global Flu Shots Revenue 2014-2025
  • 2.1.2 Global Flu Shots Sales 2014-2025
• 2.2 Flu Shots Growth Rate by Regions
  • 2.2.1 Global Flu Shots Sales by Regions
  • 2.2.2 Global Flu Shots Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Flu Shots Sales by Manufacturers
  • 3.1.1 Flu Shots Sales by Manufacturers
  • 3.1.2 Flu Shots Sales Market Share by Manufacturers
  • 3.1.3 Global Flu Shots Market Concentration Ratio (CR5 and HHI)
• 3.2 Flu Shots Revenue by Manufacturers
  • 3.2.1 Flu Shots Revenue by Manufacturers (2014-2019)
  • 3.2.2 Flu Shots Revenue Share by Manufacturers (2014-2019)
• 3.3 Flu Shots Price by Manufacturers
• 3.4 Flu Shots Manufacturing Base Distribution, Product Types
  • 3.4.1 Flu Shots Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Flu Shots Product Type
  • 3.4.3 Date of International Manufacturers Enter into Flu Shots Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Flu Shots Sales by Product
• 4.2 Global Flu Shots Revenue by Product
• 4.3 Flu Shots Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Flu Shots Breakdown Data by End User

6 North America

• 6.1 North America Flu Shots by Countries
  • 6.1.1 North America Flu Shots Sales by Countries
  • 6.1.2 North America Flu Shots Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Flu Shots by Product
• 6.3 North America Flu Shots by End User

7 Europe

• 7.1 Europe Flu Shots by Countries
  • 7.1.1 Europe Flu Shots Sales by Countries
  • 7.1.2 Europe Flu Shots Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Flu Shots by Product
• 7.3 Europe Flu Shots by End User

8 Asia Pacific

• 8.1 Asia Pacific Flu Shots by Countries
  • 8.1.1 Asia Pacific Flu Shots Sales by Countries
  • 8.1.2 Asia Pacific Flu Shots Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Flu Shots by Product
• 8.3 Asia Pacific Flu Shots by End User

9 Central & South America

• 9.1 Central & South America Flu Shots by Countries
  • 9.1.1 Central & South America Flu Shots Sales by Countries
  • 9.1.2 Central & South America Flu Shots Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Flu Shots by Product
• 9.3 Central & South America Flu Shots by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Flu Shots by Countries
  • 10.1.1 Middle East and Africa Flu Shots Sales by Countries
  • 10.1.2 Middle East and Africa Flu Shots Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Flu Shots by Product
• 10.3 Middle East and Africa Flu Shots by End User

11 Company Profiles

• 11.1 GSK
  • 11.1.1 GSK Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 GSK Flu Shots Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 GSK Flu Shots Products Offered
  • 11.1.5 GSK Recent Development
• 11.2 SINOVAC
  • 11.2.1 SINOVAC Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 SINOVAC Flu Shots Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 SINOVAC Flu Shots Products Offered
  • 11.2.5 SINOVAC Recent Development
• 11.3 CHANGSHENG
  • 11.3.1 CHANGSHENG Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 CHANGSHENG Flu Shots Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 CHANGSHENG Flu Shots Products Offered
  • 11.3.5 CHANGSHENG Recent Development
• 11.4 CCBIO
  • 11.4.1 CCBIO Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 CCBIO Flu Shots Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 CCBIO Flu Shots Products Offered
  • 11.4.5 CCBIO Recent Development
• 11.5 ALEPH BIOMEDICAL
  • 11.5.1 ALEPH BIOMEDICAL Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 ALEPH BIOMEDICAL Flu Shots Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 ALEPH BIOMEDICAL Flu Shots Products Offered
  • 11.5.5 ALEPH BIOMEDICAL Recent Development
• 11.6 SANOFI
  • 11.6.1 SANOFI Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 SANOFI Flu Shots Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 SANOFI Flu Shots Products Offered
  • 11.6.5 SANOFI Recent Development
• 11.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
  • 11.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Products Offered
  • 11.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Development
• 11.8 SIOBP
  • 11.8.1 SIOBP Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 SIOBP Flu Shots Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 SIOBP Flu Shots Products Offered
  • 11.8.5 SIOBP Recent Development
• 11.9 HUALAN BIO
  • 11.9.1 HUALAN BIO Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 HUALAN BIO Flu Shots Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 HUALAN BIO Flu Shots Products Offered
  • 11.9.5 HUALAN BIO Recent Development
• 11.10 TIANYUAN BIO-PHARMA
  • 11.10.1 TIANYUAN BIO-PHARMA Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 TIANYUAN BIO-PHARMA Flu Shots Products Offered
  • 11.10.5 TIANYUAN BIO-PHARMA Recent Development
• 11.11 VAXTEC

12 Future Forecast

• 12.1 Flu Shots Market Forecast by Regions
  • 12.1.1 Global Flu Shots Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Flu Shots Revenue Forecast by Regions 2019-2025
• 12.2 Flu Shots Market Forecast by Product
  • 12.2.1 Global Flu Shots Sales Forecast by Product 2019-2025
  • 12.2.2 Global Flu Shots Revenue Forecast by Product 2019-2025
• 12.3 Flu Shots Market Forecast by End User
• 12.4 North America Flu Shots Forecast
• 12.5 Europe Flu Shots Forecast
• 12.6 Asia Pacific Flu Shots Forecast
• 12.7 Central & South America Flu Shots Forecast
• 12.8 Middle East and Africa Flu Shots Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Flu Shots Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Flu Shots market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Flu Shots market based on company, product type, end user and key regions.

This report studies the global market size of Flu Shots in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Flu Shots in these regions.
This research report categorizes the global Flu Shots market by top players/brands, region, type and end user. This report also studies the global Flu Shots market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GSK
SINOVAC
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
SANOFI
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
SIOBP
HUALAN BIO
TIANYUAN BIO-PHARMA
VAXTEC

Market size by Product
Influenza Virus Split Vaccines
Influenza Virus Subunit Vaccines
Influenza Whole Virus Vaccines
Market size by End User
Avian Influenza virus-A
Avian Influenza virus-B

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Flu Shots market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Flu Shots market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Flu Shots companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Flu Shots submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Flu Shots are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Flu Shots market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.